![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » BAXTER AND JERINI ADVANCE PROGRAM TO DEVELOP NON-INTRAVENOUS HEMOPHILIA THERAPY
BAXTER AND JERINI ADVANCE PROGRAM TO DEVELOP NON-INTRAVENOUS HEMOPHILIA THERAPY
Baxter AG and Jerini AG today announced progress in their collaborative research program to develop a non-intravenous therapy for the treatment of hemophilia. Extensive in vitro and in vivo analysis has identified several synthetic lead molecules with promising pharmacological properties.
Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=45544)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct